Free Trial

XOMA (XOMAP) Competitors

XOMA logo
$25.44 -0.51 (-1.97%)
As of 07/3/2025 01:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

XOMAP vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying XOMA stock or one of its competitors? The main competitors of XOMA include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

XOMA vs. Its Competitors

XOMA (NASDAQ:XOMAP) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

In the previous week, XOMA had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for XOMA and 0 mentions for 180 Life Sciences. XOMA's average media sentiment score of 0.68 beat 180 Life Sciences' score of 0.00 indicating that XOMA is being referred to more favorably in the media.

Company Overall Sentiment
XOMA Positive
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
XOMAN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XOMA$13.05MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

XOMA beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks.

Get XOMA News Delivered to You Automatically

Sign up to receive the latest news and ratings for XOMAP and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XOMAP vs. The Competition

MetricXOMABiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$127.96M$5.56B$9.04B
Dividend Yield9.29%3.74%5.24%4.01%
P/E RatioN/A3.4027.6620.25
Price / SalesN/A4,084.30415.10118.18
Price / CashN/A13.1936.8958.07
Price / BookN/A42.828.035.67
Net IncomeN/A-$92.79M$3.18B$249.21M
7 Day Performance-1.43%2.47%2.93%3.27%
1 Month Performance-1.32%2.76%3.75%5.55%
1 Year Performance-1.74%189.36%35.16%21.08%

XOMA Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XOMAP
XOMA
N/A$25.44
-2.0%
N/A-3.4%$0.00$13.05M0.0010Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-1.2%
N/A-19.8%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-80.9%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.13
-21.0%
N/AN/A$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.73
+1.8%
N/A-47.3%$0.00$585.60M0.004
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
+6.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.09
-1.1%
N/AN/A$0.00$38.00M0.0070Positive News
BTMDW
biote
N/A$0.02
-10.2%
N/A-97.9%$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.07
+13.4%
N/A-70.4%$0.00N/A0.008Gap Down

Related Companies and Tools


This page (NASDAQ:XOMAP) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners